The BioIndustry Association (BIA) has asked new UK Chancellor Rachel Reeves for a nuanced approach to R&D tax credits in the ...

Screening people in primary care with a wearable heart monitor developed by iRhythm was able to increase diagnoses of atrial ...

Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure ...

Vutrisiran is already approved as Amvuttra to treat polyneuropathy caused by ATTR, but extending its indications to include ...

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the ...

ReNeuron is the latest in a lengthening list of UK biotechs saying that it is too challenging to raise capital on the AIM and ...

Welcome back to Changing Faces for the month of July. We’re trying something new this month. Rather than consigning the many ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 ...

The news comes just days after BioMarin also announced a major change to its senior leadership team aimed at boosting its ...

A virtual voice assistant that calls patients after heart procedures can allow them to be discharged from hospital earlier ...